Aurora Cannabis Inc. (ACB)

NCM – Цена в реальном времени. Валюта: USD

2.83

+0.07 (2.54%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

2.85

+0.02 (0.71%)

После закрытия: Jun 26, 2026, 7:50 PM EDT

12.06.2026

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

ACB frames fiscal 2027 as a reset year as Canadian reimbursement pressure weighs on margins, even as global medical cannabis growth continues.

12.06.2026

Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy

Aurora Cannabis reported Q4/FY2026 results largely in line with expectations previously outlined by management. In recent months, the company has made the strategic decision to exit its lower margin consumer cannabis and plant propagation operations and focus on the growing European medical cannabis market. However, FY2027 will be impacted by adverse regulatory changes in the Canadian medical cannabis market. As a result, sales and margins are expected to decline quite meaningfully this year.

11.06.2026

Aurora Cannabis Inc. (ACB:CA) Q4 2026 Earnings Call Transcript

11.06.2026

Aurora Cannabis Q4 Earnings Call Highlights

Aurora Cannabis NASDAQ: ACB reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as Canadian medical reimbursement changes weigh on revenue and margins.

11.06.2026

Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹

NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $288.6 million, representing 18% YoY growth Delivers Record Annual Adjusted EBITDA 1 of $53.8 million, representing 32% YoY growth Completes Accretive Acquisition of Safari Flower Company in April, an established EU-GMP Manufacturer, adding Critical Capacity to Serve Growing Profitable International Markets Maintains Strong Balance Sheet with ~$164.7 million of Cash, Short Term Investments and Cash Equivalents2 with no Debt EDMONTON, AB, June 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2026 periods ending March 31, 2026. "During fiscal year 2026, we exceeded our projection for global medical cannabis net revenue1 led by double-digit growth in Europe and delivered on our expectation for Adjusted EBITDA1 with both at record outcomes.

07.06.2026

Wall Street Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

02.06.2026

Aurora Deepens its Impact for Veterans Across Canada

NASDAQ | TSX: ACB From global leadership to local impact, Aurora continues to support Veteran-focused programs across Canada, addressing food security, mental health, and community engagement EDMONTON, AB, June 2, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, shares recent contributions through its Strains for Heroes program, expanding support for Veteran communities across Canada. Aurora's ongoing commitment to support Veterans includes five per cent of net profits from the sale of Strains for Heroes products being donated annually to veteran-focused organizations, up to a maximum of C$200,000.

Видео

18.01.2026

Neutral

How to play cannabis stocks in 2026

19.12.2025

Positive

Trump signs executive order to reschedule cannabis. Here's what's next

19.12.2025

Negative

Trump sparks market shock with MAJOR marijuana move

19.12.2025

Negative

Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
ACB	TD Cowen	Buy	undefined >> undefined	December 11th 2024

Пресс-релизы

11.06.2026

Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹

02.06.2026

Aurora Deepens its Impact for Veterans Across Canada

14.05.2026

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science

NASDAQ | TSX: ACB Canadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding program EDMONTON, AB, May 14, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announced today it has been granted Plant Breeders' Rights in Canada for two proprietary cannabis cultivars developed through its world-class breeding program. This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties.

28.04.2026

Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

NASDAQ | TSX: ACB Q1 launches reinforce Aurora's medical‑first strategy, expanding access to high‑quality products across multiple formats Scaled launches across Canada, Europe and Australia support growing demand in regulated international medical markets Continued focus on quality, patient needs and reliable global supply through Aurora's extensive GMP‑certified network EDMONTON, AB, April 28, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches rolling out across Canada, Europe and Australia. The company continues to shape the global cannabis landscape by introducing new products and formats around the world.

Aurora Cannabis Inc. (ACB)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Aurora Cannabis Inc. (ACB)

Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs

Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy

Aurora Cannabis Inc. (ACB:CA) Q4 2026 Earnings Call Transcript

Aurora Cannabis Q4 Earnings Call Highlights